These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 10729993
21. Interleukin-7 induces apoptosis of 697 pre-B cells expressing dominant-negative forms of STAT5: evidence for caspase-dependent and -independent mechanisms. Lanvin O, Gouilleux F, Mullié C, Mazière C, Fuentes V, Bissac E, Dantin F, Mazière JC, Régnier A, Lassoued K, Gouilleux-Gruart V. Oncogene; 2004 Apr 15; 23(17):3040-7. PubMed ID: 15048088 [Abstract] [Full Text] [Related]
22. The role of STAT5 proteins in the regulation of normal hematopoiesis in a cord blood model. Baśkiewicz-Masiuk M, Masiuk M, Czajka R, Machaliński B. Cell Mol Biol Lett; 2003 Apr 15; 8(2):317-31. PubMed ID: 12813566 [Abstract] [Full Text] [Related]
23. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM, Waxman DJ. Mol Pharmacol; 2003 Aug 15; 64(2):355-64. PubMed ID: 12869640 [Abstract] [Full Text] [Related]
24. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A, Kitamura T. Mol Cell Biol; 1998 Jul 15; 18(7):3871-9. PubMed ID: 9632771 [Abstract] [Full Text] [Related]
25. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. Moucadel V, Constantinescu SN. J Biol Chem; 2005 Apr 08; 280(14):13364-73. PubMed ID: 15677477 [Abstract] [Full Text] [Related]
26. Identification of an additional isoform of STAT5 expressed in immature macrophages. Lokuta MA, McDowell MA, Paulnock DM. J Immunol; 1998 Aug 15; 161(4):1594-7. PubMed ID: 9712020 [Abstract] [Full Text] [Related]
27. STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65. Kawashima T, Murata K, Akira S, Tonozuka Y, Minoshima Y, Feng S, Kumagai H, Tsuruga H, Ikeda Y, Asano S, Nosaka T, Kitamura T. J Immunol; 2001 Oct 01; 167(7):3652-60. PubMed ID: 11564778 [Abstract] [Full Text] [Related]
28. Stat5 tetramer formation is associated with leukemogenesis. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, Gingras S, Hoffmeyer A, Bauer A, Piekorz R, Wang D, Bunting KD, Wagner EF, Sonneck K, Valent P, Ihle JN, Beug H. Cancer Cell; 2005 Jan 01; 7(1):87-99. PubMed ID: 15652752 [Abstract] [Full Text] [Related]
29. HIV-1 infection induces a selective reduction in STAT5 protein expression. Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal DM. J Immunol; 1998 Jan 01; 160(1):28-31. PubMed ID: 9551952 [Abstract] [Full Text] [Related]
30. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein. Ross TS, Gilliland DG. J Biol Chem; 1999 Aug 06; 274(32):22328-36. PubMed ID: 10428802 [Abstract] [Full Text] [Related]
31. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. Nelson EA, Walker SR, Alvarez JV, Frank DA. J Biol Chem; 2004 Dec 24; 279(52):54724-30. PubMed ID: 15498775 [Abstract] [Full Text] [Related]
32. Initiation of polyoma virus origin-dependent DNA replication through STAT5 activation by human granulocyte-macrophage colony-stimulating factor. Watanabe S, Zeng R, Aoki Y, Itoh T, Arai K. Blood; 2001 Mar 01; 97(5):1266-73. PubMed ID: 11222369 [Abstract] [Full Text] [Related]
33. Design and use of constitutively active STAT5 constructs. Farrar MA. Methods Enzymol; 2010 Mar 01; 485():583-96. PubMed ID: 21050937 [Abstract] [Full Text] [Related]
34. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. Schuringa JJ, Chung KY, Morrone G, Moore MA. J Exp Med; 2004 Sep 06; 200(5):623-35. PubMed ID: 15353555 [Abstract] [Full Text] [Related]
35. The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines. Baśkiewicz-Masiuk M, Masiuk M, Machaliński B. Cell Prolif; 2003 Oct 06; 36(5):265-78. PubMed ID: 14521520 [Abstract] [Full Text] [Related]
36. Molecular characterization of STAT5A- and STAT5B-encoding genes reveals extended intragenic sequence homogeneity in cattle and mouse and different degrees of divergent evolution of various domains. Seyfert HM, Pitra C, Meyer L, Brunner RM, Wheeler TT, Molenaar A, McCracken JY, Herrmann J, Thiesen HJ, Schwerin M. J Mol Evol; 2000 Jun 06; 50(6):550-61. PubMed ID: 10835485 [Abstract] [Full Text] [Related]
37. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L. Blood; 1999 Aug 01; 94(3):1108-12. PubMed ID: 10419904 [Abstract] [Full Text] [Related]
38. The STATs of cancer--new molecular targets come of age. Yu H, Jove R. Nat Rev Cancer; 2004 Feb 01; 4(2):97-105. PubMed ID: 14964307 [No Abstract] [Full Text] [Related]
39. Constitutive activation of zebrafish Stat5 expands hematopoietic cell populations in vivo. Lewis RS, Stephenson SE, Ward AC. Exp Hematol; 2006 Feb 01; 34(2):179-87. PubMed ID: 16459186 [Abstract] [Full Text] [Related]
40. Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia. Theodorou M, Speletas M, Mamara A, Papachristopoulou G, Lazou V, Scorilas A, Katsantoni E. PLoS One; 2013 Feb 01; 8(10):e76155. PubMed ID: 24155890 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]